DFS vs HAE
DFS (DFS) versus Haemonetics Corporation (HAE) — a side-by-side from cached financials, not a winner call.
DFS (DFS) common stock.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
DFS does not have a complete income-statement cache yet.
Latest reported HAE revenue for 2025-03-29 was $1.36B. Net income was $167.7M. Revenue was up 4.0% from 2024-03-30 to 2025-03-29. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Not investment advice. Open the DFS and HAE stock pages for the full models.
Not investment advice.